FACTORS ASSOCIATED WITH INITIATION OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN MOROCCAN PATIENTS WITH RHEUMATOID ARTHRITIS

被引:0
|
作者
Hammou, O. [1 ]
Chennouf, F. [1 ]
Azzouzi, H. [1 ]
Linda, I. [1 ]
机构
[1] Mohammed I Univ, Mohammed Univ Hosp 6, Dept Rheumatol, Oujda, Morocco
关键词
D O I
10.1136/annrheumdis-2020-eular.5633
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0293
引用
收藏
页码:1441 / 1441
页数:1
相关论文
共 50 条
  • [1] Factors Associated with the Initiation of Biologic Disease-Modifying Antirheumatic Drugs in Texas Medicaid Patients with Rheumatoid Arthritis
    Kim, Gilwan
    Barner, Jamie C.
    Rascati, Karen
    Richards, Kristin
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (05): : 401 - 407
  • [2] Factors Associated with the Use of Biologic Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis
    Hosseini, Roya
    Fawaz, Souhiela
    Seoane-Vazquez, Enrique
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2595 - 2595
  • [3] FACTORS ASSOCIATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS UTILIZATION IN RHEUMATOID ARTHRITIS PATIENTS
    Hosseini, R.
    Brown, L.
    Rodriguez-Monguio, R.
    Seoane-Vazquez, E.
    VALUE IN HEALTH, 2022, 25 (07) : S453 - S453
  • [4] TIME TO AND FACTORS ASSOCIATED WITH INITIATION OF BIOLOGICAL THERAPY WITH DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN COLOMBIA
    Machado-Alba, J. E.
    Calvo-Torres, L. F.
    Banol-Giraldo, A. M.
    Garcia-Betancurt, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 514 - 514
  • [5] Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis
    Yinzhu Jin
    Rishi J. Desai
    Jun Liu
    Nam-Kyong Choi
    Seoyoung C. Kim
    Arthritis Research & Therapy, 19
  • [6] Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis
    Jin, Yinzhu
    Desai, Rishi J.
    Liu, Jun
    Choi, Nam-Kyong
    Kim, Seoyoung C.
    ARTHRITIS RESEARCH & THERAPY, 2017, 19
  • [7] Annual Cost of Biologic Disease-modifying Antirheumatic Drugs for Rheumatoid Arthritis
    Hosseini, Roya
    Brown, Lawrence
    Fleming, Marc
    Rodriguez-Monguio, Rosa
    Seoane-Vazquez, Enrique
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2161 - 2162
  • [8] FACTORS ASOCIATED WITH THE INITIATION OF BIOLOGIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN TEXAS MEDICAID PATIENTS WITH RHEUMATOID ARTHRITIS
    Kim, G.
    Barner, J. C.
    Rascati, K. L.
    Richards, K. M.
    VALUE IN HEALTH, 2014, 17 (03) : A42 - A42
  • [9] BONE STATUS OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
    Miladi, S.
    Ben Ayed, H.
    Makhlouf, Y.
    Boussaa, H.
    Ouenniche, K.
    Souabni, L.
    Kassab, S.
    Chekili, S.
    Ben Abdelghani, K.
    Fazaa, A.
    Laatar, A.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S447 - S447
  • [10] ANNUAL TREATMENT COST OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS
    Hosseini, R.
    Brown, L. M.
    Fleming, M.
    Rodriguez-Monguio, R.
    Seoane-Vazquez, E.
    VALUE IN HEALTH, 2024, 27 (06) : S110 - S110